Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1983-11-04
1984-07-31
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
549210, A61K 31555
Patent
active
044629982
ABSTRACT:
A pharmaceutical composition in which the active ingredient is an ascorbate complex of platinum (II) coordinated to ammonia, a monodentate amine ligand or a bidentate amine ligand as, for example, an alkylamine, an alkylenediamine or a cycloalkylamine. Said compositions are useful in the treatment of malignant tumors in animals. They may be administered orally or parenterally and they exhibit high solubility in water and low toxicity.
REFERENCES:
patent: 4140707 (1979-02-01), Cleare et al.
patent: 4211712 (1980-07-01), Marstrand
patent: 4234499 (1980-11-01), Hoeschele et al.
patent: 4234500 (1980-11-01), Hoeschele et al.
patent: 4248840 (1981-02-01), Hoeschele et al.
Marx Science, vol. 192, 5/21/76 p. 774-775.
Connors et al. Platinum Coordination Complexes in Cancer Chemotherapy, Recent Result in Cancer Research (1974), pp. XI-XII, 13-19, 38-42; 119-123.
Cleare Coordination Chemistry Review, 12(1974) pp. 349-383.
Amundsen Alan R.
Stern Eric W.
Engelhard Corporation
Fan Jane T.
LandOfFree
Method of using a cis-platinum(II) amine ascorbate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using a cis-platinum(II) amine ascorbate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using a cis-platinum(II) amine ascorbate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-185346